Legislation

HHS strips disparate-impact liability out of its Title VI regulations — final rule, effective the day it published, no comment period; 45 CFR part 80 binds every Section 330 grantee

HHS published a final rule July 24, 2026 (FR 2026-15000, RIN 0945-AA29) amending 45 CFR part 80 — its Title VI regulations — to remove provisions imposing liability based on unintentional DISPARATE IMPACT, conforming to Executive Order 14281. Verified against the Federal Register API: it is a Rule, published and EFFECTIVE the same day, with comments_close_on null — HHS issued it without prior notice and comment, invoking the APA §553(a)(2) grants-and-contracts exception after the Richardson Waiver's rescission. The rule removes and reserves 45 CFR 80.3(b)(2) — the general prohibition on using 'criteria or methods of administration which have the effect of subjecting individuals to discrimination... because of their race, color, or national origin' — and also 80.3(b)(6), 80.3(c)(3), 80.5(g), 80.5(i) and 80.5(j), while revising 80.3(b)(3) and 80.5(h). WHY IT REACHES HEALTH CENTERS: part 80 binds every recipient of HHS federal financial assistance, which includes every Section 330 grantee. READ THE SCOPE HONESTLY — THIS IS WHERE IT IS EASY TO OVERSTATE: the rule text mentions health centers, FQHCs, Section 330 and Medicaid ZERO times, and mentions LEP or 'limited English proficiency' ZERO times. The relevance is structural, not asserted by the document. Critically, SECTION 1557 IS NOT MENTIONED AND IS NOT TOUCHED by this rule, and neither are California's Dymally-Alatorre Act or Medi-Cal contract language-access requirements. Anyone telling you this rescinds your language-access obligations is inferring, not reading — Title VI's LEP framework does rest substantially on national-origin disparate-impact theory, but this rule does not make that link, and your Section 1557 and state-law duties are unchanged. What genuinely changes is the theory under which an intent-free statistical-disparity complaint could be brought against a recipient under part 80.

Arkansas AG sues 13 drugmakers + a data firm over 340B — the first time a state goes on OFFENSE under its own 340B shield law, with the state health-center association standing beside him

Arkansas Attorney General Tim Griffin filed suit July 22, 2026 in Polk County Circuit Court against 22 defendants — 13 drug manufacturers and related entities including Pfizer, Bristol Myers Squibb, AstraZeneca, Eli Lilly, Sanofi and Novo Nordisk, plus data-management firm Second Sight Solutions, LLC — alleging violations of Act 1103 of 2021 and the Arkansas Deceptive Trade Practices Act. WHY THIS IS STRUCTURALLY DIFFERENT FROM EVERY OTHER 340B CASE WE TRACK: in Washington, North Dakota, Missouri, West Virginia/Maryland, Vermont and New Mexico, the pattern is a MANUFACTURER SUING A STATE to block a contract-pharmacy law. This is the inverse — a state attorney general enforcing an enacted 340B shield law against manufacturers, in state court, seeking $10,000 per violation with total civil penalties the coverage puts above $1 billion, plus an injunction barring the restrictions. Act 1103 is the strongest possible platform for it: the 8th Circuit upheld the law and the Supreme Court declined to review it. THE ALLEGED MECHANISM IS THE PART FQHC LEADERS SHOULD READ: the state says manufacturers, unable to restrict contract pharmacies directly, pivoted to conditions Act 1103 does not expressly forbid — chiefly REQUIRING COVERED ENTITIES TO HAND OVER CLAIMS OR MEDICAL DATA to receive 340B pricing — and that each manufacturer adopted near-identical restrictions with little variance. That is the same play as the already-tracked Eli Lilly five-day claims-data ultimatum. Community Health Centers of Arkansas CEO Lanita White appeared at the announcement alongside Griffin. HONEST LIMITS: a complaint is an allegation, not a finding; no ruling exists; and the $1B figure is a sought-penalty ceiling, not a recovery. Its value to California is precedential rather than immediate — it tests whether a state 340B shield law is worth anything without an enforcer, which is the open question hanging over AB 1460.

CY2027 Physician Fee Schedule Proposed Rule Lands — CMS Proposes the FQHC PPS Base Rate Rise to $212.91 (+2.5%), Comments Close September 14

CMS published the CY2027 Physician Fee Schedule proposed rule (CMS-1848-P, FR doc 2026-14327) in today's Federal Register — 91 FR 43842–44557, comments close September 14, 2026. This resolves the watch item carried in this file's header for the last several cycles. The headline FQHC number, verbatim from the rule at 91 FR 43959: "Multiplying the CY 2026 FQHC PPS base rate amount of $207.72 by the proposed CY 2027 FQHC market basket update of 2.5 percent ($207.72 x 1.025) results in a proposed CY 2027 FQHC PPS base rate amount of $212.91." Treat $212.91 as PROVISIONAL, not locked: CMS states it will refresh the market basket and productivity adjustment at the final rule using historical data through Q2 2026, so the final figure will move. The rule also proposes conforming regulatory text (§§405.2463(b)(3), 405.2469(d)) for CAA-2026 §6209(d), which delays the RHC/FQHC in-person visit requirement for mental-health telehealth to an extended date of January 1, 2028 — note the underlying statute (Pub. L. 119-75, Feb 3 2026) is already tracked; only the regulatory codification is new here, so do not re-report the statute as news. Two honesty notes. (1) The proposed DSMT/MNT stand-alone-visit change is an RHC proposal that aligns RHCs UP to existing FQHC treatment — FQHC payment is unchanged, and it should not be framed as an FQHC win; CMS adds that it does "not expect in future rulemaking to propose additional preventive services beyond which are currently paid for in FQHCs," i.e. it considers the FQHC preventive menu complete. (2) The ACCESS Model co-management G-codes G0676/G0677/G0678 appear ZERO times in all 716 pages, as does "ACCESS Model" — the rule that would naturally have settled FQHC billing eligibility is silent, so our UNCONFIRMED framing stands and must not be upgraded.

8th Circuit Rejects Novartis's Bid to Block Missouri's 340B Contract-Pharmacy Law — Another State Shield Survives a Manufacturer Challenge

On July 1, 2026, the 8th U.S. Circuit Court of Appeals (Novartis Pharmaceuticals Corp. v. Hanaway, No. 25-1619) affirmed the district court's denial of Novartis's preliminary-injunction bid against Missouri's S.B. 751, which requires manufacturers to deliver 340B drugs to all contract pharmacies serving Missouri covered entities. Per the Missouri Hospital Association, the court found Novartis unlikely to prevail on the merits — any extraterritorial effect of the statute was 'negligible and nondiscriminatory toward out-of-state entities' — and rejected Novartis's attempt to revisit its position on federal preemption; the case now returns to the district court for merits proceedings. The Missouri Primary Care Association (the state's FQHC association) intervened alongside MHA to defend the law. The ruling adds another upheld state 340B contract-pharmacy shield to the circuit-by-circuit map FQHC pharmacy directors are tracking, weeks after Washington's law survived a separate challenge in June.

AHA Files En Banc Review Petition After 4th Circuit Blocks WV 340B Contract Pharmacy Law — Decision Expected Mid-May

American Hospital Association filed en banc review petition April 17 after 4th Circuit panel blocked West Virginia's S.B. 325 (which forced manufacturers to ship 340B drugs to contract pharmacies). Combined with the 4th Circuit's April 14 vacatur of Maryland's similar law, drugmakers won two consecutive 4th Circuit rulings. AHA argues panel decision conflicts with 5th and 8th Circuit rulings, citing critical importance of preserving state-level 340B protections. Decision window typically 30 days. Outcome shapes whether other 4th Circuit states (NC, SC, VA) can pass 340B contract pharmacy access laws — and indirectly affects circuit-split posture for likely Supreme Court review.

25 States + DC Sue HHS/CMS Over the Work-Requirement Rule's Narrowed 'Medically Frail' Exemption — the First Direct Legal Challenge to the IFR

A coalition of 25 states plus the District of Columbia — with California AG Rob Bonta among the co-leads alongside Massachusetts and New Jersey — filed Commonwealth of Massachusetts v. Oz (1:26-cv-12962, U.S. District Court for the District of Massachusetts) on June 29, 2026: the first direct legal challenge to CMS's Medicaid work-requirement interim final rule (CMS-2454-IFC). The suit targets 42 CFR 435.554(c)(5)(i). H.R. 1's statute exempts people with qualifying conditions (disability, substance use disorder, serious mental illness) as 'medically frail' — but the rule adds a requirement that they ALSO prove the condition 'significantly impairs' their ability to comply with the 80-hour/month community-engagement requirement, a 'sick enough' test the states argue violates the APA and dramatically narrows who stays exempt. The medical-frailty exemption is the single biggest determinant of how many of the ~5.6M community health center patients subject to the requirement keep coverage after January 1, 2027 — and FQHC clinical and eligibility teams are the ones who will document frailty either way. The August 31, 2026 deadline for states to begin beneficiary notification adds urgency: watch for a preliminary-injunction ruling before then.

Senate HELP Chair Cassidy Releases Comprehensive 340B Reform Discussion Draft — the Federal Rewrite Vehicle Arrives

Senate HELP Committee Chair Bill Cassidy (R-LA) released a legislative discussion draft of the '340B Drug Pricing Integrity and Affordability for Patients Act' on June 25, 2026 — the most comprehensive federal 340B rewrite vehicle to emerge this cycle. Key provisions per the committee release and STAT coverage: restrictions on hospital 'child sites' (which would need to provide services beyond drug dispensing and be located in shortage areas) and a requirement that hospital covered entities adopt sliding fee scales — a discipline FQHCs already live under by statute. For health centers, the draft lands in a crowded field: the health-center-side '340C' proposal (a voluntary, transparent subset with contract-pharmacy protection and WAC reimbursement for Medicaid drugs) and the already-tracked bipartisan H.R. 7391 340B FQHC Protection Act remain the CHC counter-positions. Strategic read: most of Cassidy's draft targets hospital behavior, not health centers — but any comprehensive 340B rewrite that moves opens the whole program, contract-pharmacy rules included, while the December 31 CHC Fund cliff still has no legislative vehicle of its own. Status: discussion draft (not yet introduced); comment and stakeholder engagement expected over summer 2026.

The work-requirement map, 6 months out: 4 states going early, Nebraska's freeze is the preview, and Georgia's 5% enrollment rate is the warning

With CMS-2454-IFC taking effect July 31 (the Federal Register DATES section publishes an effective date only, no comment deadline — corrected 2026-07-22) and full implementation due January 1, 2027, the state map has taken shape. Four states are going early: Nebraska (enforcing since May 1), Montana (July 1), Arkansas (soft launch July 1), and Iowa (December 1, with no high-unemployment hardship exception) — plus Idaho (Dec 31 statutory deadline with the nation's longest 3-month lookback) and Kentucky (HB 2's pre-enrollment proof requirement, enacted over the governor's veto). Nebraska's 'soft start' is producing the first hard national data: ZERO new Medicaid enrollees in May versus a typical ~15/month at the state's health centers (a pure chilling effect — termination checks don't even begin until July 31), with 20,000-28,000 of ~70,000 expansion enrollees flagged for documentation. Georgia's Pathways — the only mature work-requirement program — has enrolled ~16,183 people in three years, about 5% of its potential population. Two mitigations worth copying: Utah exempted homeless individuals (FQHC-designed, NACHC-endorsed), and Oregon exempted FQHC visits from new cost-sharing. The operational takeaway repeats Nebraska's lesson everywhere: the chilling effect arrives before the disenrollments do, and clinics' navigation capacity is the rail it all runs on.

MACPAC's June report hands FQHCs two federal hooks: a work-requirement monitoring mandate and a human-review requirement for AI prior-auth denials

MACPAC — Congress's independent Medicaid advisory commission — voted 15-2 to recommend that CMS publish a transparent monitoring and evaluation plan for the H.R. 1 community-engagement (work) requirements before the January 1, 2027 implementation, anchored on minimizing administrative burden, timely public state data, and measuring actual employment and health outcomes. The same June 2026 report cycle carries four recommendations on automation in Medicaid prior authorization: every adverse PA determination must be reviewed by a human with relevant clinical expertise (automation alone cannot deny), CMS must extend the same rule to fee-for-service, issue managed-care AI oversight guidance, and require MCOs to disclose AI use to states. For FQHCs juggling 10-20 Medicaid MCO contracts, the human-review recommendation is the federal counterweight to algorithmic denial engines — and the monitoring framework gives state PCAs the yardstick to hold their Medicaid agencies to as work requirements roll out.

Washington's 340B protection law survives — and the national map now splits clean: 22 state laws, two circuits upholding, one blocking, DOJ siding with manufacturers

On June 9, 2026 a federal judge denied AbbVie, AstraZeneca, Novartis, and PhRMA's bid to block Washington's SB 5981, letting the nation's 22nd state 340B contract-pharmacy protection law take effect June 10 with penalties up to $5,000/day. The ruling sharpens the cleanest circuit split in health law: the 5th Circuit upheld Louisiana's law (Feb 9) and Mississippi's in two separate cases (Apr 9), Minnesota's state appeals court upheld its law (Feb 17) — while the 4th Circuit blocked West Virginia's as likely federally preempted (Mar 31) and a North Dakota judge struck that state's law in April. Two more wrinkles tilt the field: the Trump DOJ filed amicus briefs in the Colorado and Rhode Island cases (Feb 2026) backing the manufacturers' preemption theory — a first — and Kansas becomes the only state moving backward, its protections expiring June 30 after the renewal bill died. Multiple law firms now expect Supreme Court review. For multi-state FQHC networks, 340B contract-pharmacy security now varies by federal judicial circuit; the NACHC state-law tracker is the canonical map.

Final California Primary Results Put Xavier Becerra and Steve Hilton in the November 3 Governor Runoff

California's final official Statement of Vote resolves the uncertainty recorded in the original June 5 item. Xavier Becerra finished first with 2,591,857 votes (28.0%), and Steve Hilton finished second with 2,277,318 votes (24.6%); under California's top-two system, they advance to the November 3 general election. Tom Steyer did not advance. For FQHC planning, this is an election-landscape signal rather than immediate operating relief: the next governor takes office after the December 31, 2026 federal health-center funding deadline and the January 1, 2027 start of major Medi-Cal eligibility changes.

California Budget Deadlocks 11 Days Before the Deadline — Senate Wants a $285/Employee Fee Instead of Renewing the $4.5B MCO Tax That Funds Medi-Cal Rates

Historical standoff record: as of June 4 — with the June 15 constitutional budget deadline 11 days out — Governor Newsom and the Assembly (who wanted to renew the long-standing Managed Care Organization tax, ~$4.5B/year) were deadlocked with the state Senate, which instead proposed a new $285/employee/month fee on large employers for each worker enrolled in Medi-Cal. The MCO tax expires December 31, 2026; it is the mechanism California uses to draw down federal matching dollars that fund the Medi-Cal primary-care, maternal-care, and non-specialty behavioral-health rate increases — the rate floor FQHCs rely on to supplement non-PPS revenue. Signed-budget update: the June 29 budget renewed the MCO-tax path and moved the major UIS/PPS clinic-payment cut into a July 1, 2027 planning horizon, so the live CFO risk is 2027 sensitivity plus January 2027 Medicaid work requirements rather than a July 2026 PPS hit.

CMS Publishes the Medicaid Work-Requirements Rule (CMS-2454-IFC) — 80 Hours/Month, Effective July 31, States Must Implement by Jan 1, 2027

On June 1, 2026 — ahead of its June statutory deadline — CMS issued the interim final rule implementing H.R. 1's Medicaid 'community engagement' (work) requirement. Adults in the expansion group must document 80 hours/month of qualifying activity (employment, work programs, community service, or at-least-half-time education) — or earn roughly $580/month — to keep coverage. The rule is effective July 31, 2026 (the comment period closes the same day), states must begin member outreach by August 31, and full implementation is required by January 1, 2027; it also tightens illness/incapacity exemption eligibility. The Commonwealth Fund estimates 5.6 million community-health-center patients are exposed nationwide. This is the operational floor FQHCs in both California and Texas have been waiting on: it converts the abstract 'work requirement' into a concrete navigation problem — every center now has roughly four weeks to finalize its eligibility-redetermination and patient-navigation playbooks before the state outreach window opens. The rule resolves the platform's two prior 'watch' items (it was due; it is now published).

CMS Interim Final Rule on Medicaid Work Requirements Published June 1 — Defines Exemptions, Reporting, and Enforcement

CMS published an Interim Final Rule (CMS-2454-IFC) on June 1, 2026 defining critical work requirement implementation details: exemption criteria, reporting mechanisms, compliance verification, and non-compliance consequences. The 80-hour/month requirement scope depends entirely on this rule — narrow exemptions could mean millions losing coverage, broad exemptions could limit damage. States must conduct member outreach June 30–August 31, 2026. CMS is distributing $200M in 'Government Efficiency Grants' for state tracking systems, but no direct funding flows to FQHCs despite bearing the patient-facing burden.

HHS Medicaid Work-Requirements Interim Final Rule Published June 1 — FQHC Eligibility Teams Need a Playbook Now

HHS published the Interim Final Rule (CMS-2454-IFC) implementing H.R. 1's Medicaid community-engagement (work) requirements on June 1, 2026. The rule will define operational standards: verification methods, qualifying activities, exemption criteria, and how the 80-hr/month threshold is measured. States must then conduct mandatory member outreach between June 30 and August 31, 2026, ahead of the December 31, 2026 implementation deadline. Commonwealth Fund estimates 5.6M CHC patients are at risk of losing Medicaid under this framework. Strategic implication: FQHC eligibility and enrollment teams have ~30 days from rule publication to retrain staff before the June 30 state-outreach window opens. Late or vague guidance = redetermination chaos in FQHC navigation workflows starting July 1. CA's outreach burden is one of the largest in the country (~5M expansion enrollees). Pair with CHAI/NACHC Medicaid-eligibility AI Best Practice Guides (already tracked) — those provide the AI guardrails; this rule sets the legal floor.

California's 4-Bill H.R. 1 Mitigation Package Advances — Cost-Sharing Cap, Retroactive Coverage, Renewal Automation, Disenrollment Dashboard

A four-bill California package designed to blunt H.R. 1's Medi-Cal damage advanced through Appropriations (May 14) and onto floor votes the week of May 22-26 — co-sponsored by Western Center on Law & Poverty, Justice in Aging, the National Health Law Program, and Health Access California. AB 2208 (Stefani) passed the Assembly 58-19 on May 26: it caps H.R. 1-triggered Medi-Cal cost-sharing at 1 cent per service and restores the full 3-month retroactive coverage window with state funds (H.R. 1 cut it to 1 month for expansion adults). Retroactive coverage is a direct FQHC revenue protection — it lets centers bill for care delivered before eligibility is finalized. AB 2201 (Boerner) automates Medi-Cal renewal verification to reduce churn from H.R. 1's new 6-month redetermination cycle. SB 1202 (Weber-Pierson) requires DHCS to publish a public dashboard tracking H.R. 1-attributable disenrollments — official data FQHCs can use to quantify coverage loss in their service area. Strategic implication for CA FQHCs: AB 2208's retroactive-coverage restoration is the most balance-sheet-relevant; track all four through the second house and the June budget.

CMS Proposes Medicare-Based Caps on Medicaid State-Directed Payments (CMS-2449-P) — Comments Close July 21

CMS's proposed rule on Medicaid managed-care state-directed payments and fee-for-service targeted Medicaid practitioner payments (CMS-2449-P, published in the Federal Register May 22, 2026; FR doc 2026-10292) implements Section 71116 of H.R. 1, proposing to cap total payment rates for targeted services at 100% of the published Medicare rate in expansion states and 110% in non-expansion states. Compliance would begin January 1, 2029, with grandfathered state-directed payments phasing down 10 percentage points a year starting January 1, 2028; CMS projects roughly $775 billion in total savings over ten years (~$510B federal). The Association of Clinicians for the Underserved flags the stakes for safety-net providers, noting Medicaid payment 'is already often below the cost of providing care.' Comments are due July 21, 2026 (docket CMS-2026-1916) — the near-term action item for state PCAs and health-center advocates in states that use directed payments to lift Medicaid rates.

AB 403 Would Force DHCS to Publicly Report CHW/Promotora Medi-Cal Use — After Fewer Than 6,000 of 15M Beneficiaries Accessed the Benefit

AB 403 (Asm. Liz Ortega, D-20) — the Community Health Worker/Promotora/Representative Medi-Cal Services Transparency Act — would require DHCS, beginning July 1, 2027, to publish an annual analysis of CHW Medi-Cal benefit utilization, reimbursements, and CHW/beneficiary demographics. The driver: of roughly 15 million Medi-Cal beneficiaries, fewer than 6,000 have accessed CHW services and under $1 million has been reimbursed since the benefit launched — evidence the benefit is badly underused. Co-sponsors: Latino Coalition for a Healthy California, California Pan-Ethnic Health Network, Visión y Compromiso, and The Children's Partnership. Strategic implication for FQHC leaders: FQHCs are the primary CHW/ECM billing providers, so mandated public reporting will surface site-level CHW utilization and strengthen the advocacy case for raising the CHW Medi-Cal rate. This is distinct from SB 184 (CHW certification). The bill is advancing through the 2025-26 session; May 29 is the house-of-origin passage deadline.

CA AB 2756 Would Force DHCS to Publicly Report Medi-Cal Vision Quality — After Data Shows Only 16% of Medi-Cal Kids Got Eye Care

AB 2756 (Ahrens), sponsored by the California Optometric Association, passed the Assembly floor 78-0 on May 26, 2026 and now moves to the Senate. It would require DHCS to establish and publicly report equity-stratified Medi-Cal vision quality, access, and utilization measures with annual benchmarks. The bill follows an April 2, 2026 CalMatters/COA report finding only 16% of school-age Medi-Cal children received eye care in 2022-24 (down from 19%), declines in 47 of 58 counties, and a ~$47 comprehensive exam rate unchanged for 25 years — leaving only ~10% of COA optometrists accepting Medi-Cal. Strategic implication for FQHC leaders: (1) FQHCs are core Medi-Cal pediatric vision providers — mandated DHCS reporting will surface site-level performance and raise screening/referral expectations; (2) the rate-stagnation spotlight strengthens the case for vision-service revenue investment (see our Vision Care briefing); (3) pair AB 2756 advocacy with the stalled NHSC Improvement Act (HR 920/S.1445) that would restore optometrist NHSC eligibility for recruitment; (4) FQHCs with optometry should benchmark their pediatric eye-exam rates now, ahead of public reporting.

LA Measure ER on June 2 Ballot — 'Essential Services Restoration Act' Polling 45/47 Against, 12 Days to ~$1B/yr Safety-Net Backfill Vote

Los Angeles County Measure ER — officially the 'Essential Services Restoration Act for Los Angeles County' — heads to voters June 2, 2026 with polling showing 47% opposed vs. 45% in favor. The half-cent sales tax (0.5%) for 5 years (Oct 2026 → 2031) generates ~$1B/year for safety-net hospitals and clinics. Exclusions: groceries, prescription drugs, medical equipment. If it fails: LA County FQHCs lose key state/local backfill against ~$1.5B in federal cuts; KFF reports DHS's $6.5B budget is 70% Medicaid-dependent with $750M revenue loss by FY2027-28 (~10% revenue loss); some LA clinic networks could lose 20% of annual budget. Strategic implication for LA FQHC executives: (1) Mobilize patient/community voter education TODAY — 12-day window; (2) Brief boards on Plan B scenarios for failure case (Sept 2026 budget revisions, layoff timing, sliding-fee expansion costs); (3) Coordinate get-out-the-vote with CCALAC's 450+ LA County health center site network; (4) Engage AltaMed, St. John's, LA LGBT Center, Eisner, Watts, Venice Family, Northeast Valley, T.H.E., El Proyecto, Clinica Romero on coordinated messaging before June 2.

CalAIM 1115 Waiver Renewal Pending at CMS — ECM/Community Supports Funding on the Dec 31, 2026 Cliff

California's CalAIM 1115 waiver renewal application comment period closed March 12, 2026, with the existing waiver expiring December 31, 2026. CMS approval is pending — negotiations are expected to run through most of 2026, with a decision anticipated near the December 31 expiration. Without renewal, the Enhanced Care Management (ECM), Community Supports, and CalAIM transformation funding stream disappears — threatening thousands of FQHC care coordination, CHW, housing navigator, and care manager positions. Combined with the December 2026 CR cliff for Community Health Center Fund ($4.6B/yr) and Health Resources and Services Administration appropriations, FQHCs face a structural dual December 2026 funding cliff. Strategic implication for FQHC CFOs and program directors: (1) Stress-test FY27 budgets under a 'no CalAIM' scenario, (2) Identify which ECM staff positions are CalAIM-funded vs. PPS-funded, (3) Build a Plan B for housing navigator and CHW roles dependent on Community Supports funding, (4) Engage CPCA and CCALAC for early intelligence on CMS approval signals.

LA Measure ER on June 2 Ballot — $1B/Year Sales Tax for FQHCs + Public Hospitals, Polling Shows 47% No / 45% Yes

LA County Measure ER — a half-cent sales tax raising the county rate to 10.25% — appears on the June 2, 2026 ballot. Projected revenue: $1B/year for Medi-Cal providers (FQHCs and public hospitals) through 2031. May polling shows 47% opposed, 45% in favor — a narrow margin with 8% undecided. If passes: largest local healthcare tax in LA County history with 9-member oversight committee + Auditor-Controller audits. If fails: zero local backfill against federal Medicaid cuts. Strategic implication: every LA FQHC (AltaMed, St. John's, Eisner, Northeast Valley, Watts, KHEIR, LA LGBT Center, Harbor, APHCV, El Proyecto) has revenue at stake. Coalition behind the measure includes 'Restore Healthcare for Angelenos' (already tracked). This is the most consequential FQHC funding event in LA County in years — and the 22-day window between today and election day is the highest-leverage period for FQHC executives to amplify pro-Measure-ER messaging through staff, board, and patient channels.

AB 108 Signed — $25M Emergency Grants for Distressed Hospitals + Senate Proposes $200M Expansion (Precedent for FQHC Liquidity Grants)

Governor Newsom signed AB 108 in early May 2026, creating a $25M one-time emergency grant fund for distressed hospitals (eligibility: nonprofit/public, <10 days cash on hand, exhausted other options, >50% Medi-Cal/uninsured patient base). Senate budget proposal adds $200M for FY2026-27. While criteria currently target hospitals not FQHCs, this is the precedent CPCA and NACHC have been arguing for: a state-level emergency liquidity backstop for safety-net providers. Strategic implication for CA FQHCs: (1) CPCA should push to extend distressed-provider grant logic to FQHCs in the FY2026-27 budget conference; (2) FQHCs already on cash-flow watch should document <10-day cash positions, exhausted-options narratives, and >50% Medi-Cal/uninsured exposure for future eligibility arguments; (3) watch the Senate $200M expansion for FQHC inclusion language. The bill establishes the political logic that California will not let safety-net providers fail in the H.R. 1 era. Pairs with the BHCIP $5.8B announcement as the 'California is building backstops' narrative — important for staff retention and board confidence.

Federal Government Appeals 340B Child Site Ruling — FQHC Site-Expansion Strategies Back in Legal Limbo

The federal government has appealed the March 3, 2026 district court ruling that struck down HRSA's 340B child site registration requirement. The original ruling let 340B child sites access discounts immediately upon opening — without waiting for Medicare cost report filing and HRSA database registration. That was a significant operational win for FQHCs expanding sites (especially during the H.R. 1 site-multiplication strategy CFOs have been pursuing). An appeal could reverse that win, force FQHCs back to delayed eligibility (potentially 6-18 months of delayed 340B savings on new sites), and disrupt FQHC site-expansion strategies. The government may also seek a stay during appeal — which would effectively pause the favorable ruling while the appellate court considers it. Strategic implication: any FQHC that announced or is mid-flight on new site openings should immediately: (1) document existing 340B savings projections, (2) prepare contingency revenue forecasts assuming delayed eligibility, (3) coordinate with NACHC for amicus support if the appellate timeline accelerates. Pairs with the 4th Circuit contract pharmacy ruling already tracked — 340B litigation is a constant moving target through 2026.

Newsom May Revision Drops Mid-May 2026 — FQHC Watch Items: H.R. 1 Absorption, MCO Tax, Prop 35 Allocations, Worker Reqs Cost

Historical baseline: California Governor Newsom's FY2026-27 May Revision was expected mid-May 2026, his last gubernatorial budget. The January proposed budget projected a $2.9B deficit and $1.1B in net Medi-Cal cost pressure from H.R. 1 absorption. Items CA FQHC executives were tracking in the May Revision included the State-Only/UIS PPS-to-FFS proposal, MCO Tax permanence via Prop 35 allocations to FQHC PPS supplemental rates, work/community engagement requirements, the federal admin match cut, and capacity for Rural Health Transformation funding. The signed budget moved the major UIS/PPS clinic-payment reduction into a July 1, 2027 planning horizon pending final DHCS implementation guidance, so use this item as context for what was on the table in May and how the live posture changed.